Avantor added to ‘Tactical Outperform’ list, target trimmed at Evercore ISI

Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Avantor to $27 from $28 and keeps an Outperform rating on the shares and is adding the stock to the firm’s “Tactical Outperform” list ahead of earnings. Expectations have come down since management’s reiteration of second half guidance the firm thinks an inline quarter and guidance reiteration “should be enough for shares to rebound,” the analyst tells investors in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.